You are correct. There was a cure for Hep C Fingers - and there was another company as well that beat BIT in commercialisation - but BIT was the first to announce it. I first invested in BIT in 2012 because of the positive trials with HepC.
HepB is the hard one and the most dangerous. I think BIT is doing some research with that one.
$10 Billion Deal, page-11966
-
- There are more pages in this discussion • 1,302 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
